Kevin Pollack
Overview
Kevin Pollack received an average of $2M in total compensation, including $334K in salary, at OPIANT PHARMACEUTICALS from 2012 to 2016.
Source: SEC filings on July 27, 2017, December 3, 2015, and September 11, 2014.
Related executives
We found three more executives who work or worked at OPIANT PHARMACEUTICALS.